Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-14-018572
Filing Date
2014-03-28
Accepted
2014-03-28 12:04:45
Documents
1
Group Members
CALEY CASTELEINJAMES SHAPIROKEARNY VENTURE ASSOCIATES, L.L.C.KEARNY VENTURE PARTNERS ENTREPRENEURS' FUND, L.P.RICHARD SPALDINGTHOMAS WEISEL HEALTHCARE VENTURE PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v373048_sc13d.htm SC 13D 114674
  Complete submission text file 0001144204-14-018572.txt   116325
Mailing Address 88 KEARNY ST SAN FRANCISCO CA 94108
Business Address 88 KEARNY ST SAN FRANCISCO CA 94108
Kearny Venture Partners LP (Filed by) CIK: 0001376359 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Subject) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88058 | Film No.: 14724300
SIC: 2834 Pharmaceutical Preparations